<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04704427</url>
  </required_header>
  <id_info>
    <org_study_id>LYS[2020]-133</org_study_id>
    <nct_id>NCT04704427</nct_id>
  </id_info>
  <brief_title>Rehabilitative BCI in Acute Ischemic Stroke</brief_title>
  <official_title>Rehabilitative BCI for Lower Limb Function Recovery in Acute Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to explore the role and expound the mechanism of rehabilitative brain computer&#xD;
      interface (BCI)-based training (referred to as the Walk Again Neurorehabilitation protocol)&#xD;
      in neurofunctional reconstruction in acute phase of cerebral infarction, the investigators&#xD;
      choose non-invasive BCI to study lower limb function of patients with acute cerebral&#xD;
      infarction. The investigators evaluate lower limb function, the influence on the central&#xD;
      brain functional network and relevant immuno-inflammatory indicators, so that the&#xD;
      investigators can explore the therapeutic effect and mechanism in the acute phase of cerebral&#xD;
      infarction and provide theoretical bases and feasible guidances for the treatment of&#xD;
      post-stroke dyskinesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The participants will be randomly divided into experimental group and control group. The&#xD;
      experimental group will receive BCI-based lower limb functional training, 30 minutes per&#xD;
      time, 5 times per week, with a 4-week training period; the control group will only receive&#xD;
      routine lower limb training, with the same treatment frequency, intensity and duration.&#xD;
      Statistical analysis will be performed to compare the relevant evaluation indexes of the&#xD;
      experimental group and the control group after treatment and 90 days. In this study, the&#xD;
      investigators will use Lower Extremity Fugl-Meyer Assessment (LE-FMA) to comprehensively&#xD;
      evaluate the function of lower limbs, Functional Ambulation Category Scale (FAC) and 10-meter&#xD;
      walking test (10MWT) for walking ability, modified Barthel index (MBI) for daily living&#xD;
      abilities, functional magnetic resonance imaging（fMRI）and near infrared functional brain&#xD;
      imaging (NIRS) to evaluate brain function and network reconstruction, the translocator&#xD;
      protein(TSPO)-positron emission tomography (PET) and blood immune inflammation indicators to&#xD;
      evaluate systemic and intracranial immune status.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 16, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Fugl-Meyer score of lower limbs from baseline to 4 weeks.</measure>
    <time_frame>0-4 weeks.</time_frame>
    <description>It consists of 17 individual assessments that are summed to generate a total score. Scores range from 0-34, the higher the better.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional ambulation category scale</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>This scale indicates the ability to walk independently and serves as the primary outcome measure.Participants will be asked to walk at their normal comfortable pace (handheld assistive device is acceptable if needed).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10-meter walk test</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>Gait speed will be measured as the average of 3 times 10-meter walk tests. Participants will be asked to walk at their normal comfortable pace (handheld assistive device is acceptable if needed).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Barthel index</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>Scale range: 0-100 (with higher scores indicating a greater ability to complete activities of daily living)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institutes of Health Stroke Scale</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. The range of scores is from 0 (normal) to 42, with higher scores indicating greater stroke severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait analysis ( stride frequency, step length and velocity)</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>To evaluate the walking ability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nodal functional connectivity strength analysis by functional magnetic resonance imaging</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>To evaluate the brain function and network</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in oxyhaemoglobin in related cortex by Functional near-infrared spectroscopy</measure>
    <time_frame>4 weeks and 90 days.</time_frame>
    <description>To evaluate the brain cortex function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The translocator protein(TSPO)-positron emission tomography (PET)</measure>
    <time_frame>4 weeks.</time_frame>
    <description>Respond to inflammation in the brain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer score of lower limbs</measure>
    <time_frame>90 days.</time_frame>
    <description>It consists of 17 individual assessments that are summed to generate a total score. Scores range from 0-34, the higher the better.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Rehabilitative BCI training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will receive brain computer interface-based lower limb function training (BCI-LLT), 30 minutes/time, 5 times/week, with a 4-week training period.. The training using the lower limb orthosis targeted the patient's ability to walk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional physical therapy protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will only receive traditional physical therapy protocol. The traditional physical therapy protocol of lower limb conducted with the same treatment frequency, intensity and duration of treatment, including muscle strength training, balance training and walking training, etc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive BCI training</intervention_name>
    <description>In the experimental group, the participants receive non-invasive rehabilitative BCI training. The training using the lower limb orthosis targeted the patient's ability to walk.</description>
    <arm_group_label>Rehabilitative BCI training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional Physiotherapy protocol</intervention_name>
    <description>In the control group，the participants receive the traditional physiotherapy protocol, including muscle strength training, balance training and walking training, etc.</description>
    <arm_group_label>Traditional physical therapy protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The diagnosis of cerebral infarction conforms to the diagnostic criteria of &quot;Chinese&#xD;
             guidelines for diagnosis and treatment of acute ischemic stroke 2018&quot;.&#xD;
&#xD;
          2. 35 ≤ age ≤ 60 .&#xD;
&#xD;
          3. Onset (last-seen-well) time to randomization time from 24-72 hours.&#xD;
&#xD;
          4. First onset.&#xD;
&#xD;
          5. The lesion is assessed by MRI as a single subcortical infarction of the anterior&#xD;
             circulation.&#xD;
&#xD;
          6. 5 ≤NIHSS≤15 (and 1 ≤6a/b≤3 ).&#xD;
&#xD;
          7. 1 ≤FAC functional walking scale score ≤ 3.&#xD;
&#xD;
          8. Signed informed consent from subject or legally authorized representative.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unstable vital signs.&#xD;
&#xD;
          2. Progressive stroke.&#xD;
&#xD;
          3. Patients have received intravenous thrombolysis or endovascular treatment.&#xD;
&#xD;
          4. Cardiogenic cerebral embolism.&#xD;
&#xD;
          5. Presence of moderate or higher vascular stenosis or vulnerable plaque based on Imaging&#xD;
             assessment.&#xD;
&#xD;
          6. With other diseases of the nervous system.&#xD;
&#xD;
          7. With serious diseases of other systems (severe circulatory system, respiratory system,&#xD;
             motor system) and other diseases unsuitable for training, such as atrial fibrillation,&#xD;
             heart failure, lung infection, severe liver or kidney insufficiency, lower extremity&#xD;
             venous thrombosis.&#xD;
&#xD;
          8. Lower limb dysfunction caused by other reasons, such as fracture, lower limb&#xD;
             deformity, etc.&#xD;
&#xD;
          9. With contraindications in imaging examinations, such as metal implantation, fear of&#xD;
             claustrophobia, and severe obesity.&#xD;
&#xD;
         10. Patient who cannot cooperate with training, such as mental disorders, cognitive&#xD;
             dysfunction, Mini-Mental State Examination (MMSE) &lt;21 points, etc.&#xD;
&#xD;
         11. Other reasons: alcoholism; pregnancy; skull defect; indwelling urinary catheter;&#xD;
             vision defects affect training, etc.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoguang Zhao</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Junwei Hao, MD,PHD</last_name>
    <phone>010-83199088</phone>
    <email>haojunwei@vip.163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haijie Liu, MD,PHD</last_name>
    <phone>+8615822841534</phone>
    <email>haijieliu@163.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Jackson A, Zimmermann JB. Neural interfaces for the brain and spinal cord--restoring motor function. Nat Rev Neurol. 2012 Dec;8(12):690-9. doi: 10.1038/nrneurol.2012.219. Epub 2012 Nov 13. Review.</citation>
    <PMID>23147846</PMID>
  </reference>
  <reference>
    <citation>Ramos-Murguialday A, Broetz D, Rea M, Läer L, Yilmaz O, Brasil FL, Liberati G, Curado MR, Garcia-Cossio E, Vyziotis A, Cho W, Agostini M, Soares E, Soekadar S, Caria A, Cohen LG, Birbaumer N. Brain-machine interface in chronic stroke rehabilitation: a controlled study. Ann Neurol. 2013 Jul;74(1):100-8. doi: 10.1002/ana.23879. Epub 2013 Aug 7.</citation>
    <PMID>23494615</PMID>
  </reference>
  <reference>
    <citation>López-Larraz E, Sarasola-Sanz A, Irastorza-Landa N, Birbaumer N, Ramos-Murguialday A. Brain-machine interfaces for rehabilitation in stroke: A review. NeuroRehabilitation. 2018;43(1):77-97. doi: 10.3233/NRE-172394. Review.</citation>
    <PMID>30056435</PMID>
  </reference>
  <reference>
    <citation>Chaudhary U, Birbaumer N, Ramos-Murguialday A. Brain-computer interfaces for communication and rehabilitation. Nat Rev Neurol. 2016 Sep;12(9):513-25. doi: 10.1038/nrneurol.2016.113. Epub 2016 Aug 19. Review. Erratum in: Nat Rev Neurol. 2017 Feb 17;13(3):191.</citation>
    <PMID>27539560</PMID>
  </reference>
  <reference>
    <citation>Lebedev MA, Nicolelis MA. Brain-Machine Interfaces: From Basic Science to Neuroprostheses and Neurorehabilitation. Physiol Rev. 2017 Apr;97(2):767-837. doi: 10.1152/physrev.00027.2016. Review.</citation>
    <PMID>28275048</PMID>
  </reference>
  <reference>
    <citation>Donati AR, Shokur S, Morya E, Campos DS, Moioli RC, Gitti CM, Augusto PB, Tripodi S, Pires CG, Pereira GA, Brasil FL, Gallo S, Lin AA, Takigami AK, Aratanha MA, Joshi S, Bleuler H, Cheng G, Rudolph A, Nicolelis MA. Long-Term Training with a Brain-Machine Interface-Based Gait Protocol Induces Partial Neurological Recovery in Paraplegic Patients. Sci Rep. 2016 Aug 11;6:30383. doi: 10.1038/srep30383.</citation>
    <PMID>27513629</PMID>
  </reference>
  <reference>
    <citation>Selfslagh A, Shokur S, Campos DSF, Donati ARC, Almeida S, Yamauti SY, Coelho DB, Bouri M, Nicolelis MAL. Non-invasive, Brain-controlled Functional Electrical Stimulation for Locomotion Rehabilitation in Individuals with Paraplegia. Sci Rep. 2019 May 1;9(1):6782. doi: 10.1038/s41598-019-43041-9. Erratum in: Sci Rep. 2019 Dec 4;9(1):18654.</citation>
    <PMID>31043637</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2021</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain Computer Interface</keyword>
  <keyword>Lower Limb Function Recovery</keyword>
  <keyword>Brain Machine Interface</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

